{"id":236085,"date":"2023-11-30T11:09:07","date_gmt":"2023-11-30T10:09:07","guid":{"rendered":"https:\/\/fefac.cat\/empresarial\/?p=236085"},"modified":"2023-11-30T11:09:13","modified_gmt":"2023-11-30T10:09:13","slug":"denuncien-sanitat-efectes-secundaris-nolotil","status":"publish","type":"post","link":"https:\/\/fefac.cat\/empresarial\/denuncien-sanitat-efectes-secundaris-nolotil\/","title":{"rendered":"Denuncien a Sanitat pels efectes secundaris del Nolotil"},"content":{"rendered":"\n<h2 class=\"wp-block-heading\">El Nolotil (metamizol) est\u00e0 prohibit en prop de 40 pa\u00efsos pels seus greus efectes secundaris<\/h2>\n\n\n\n<p>El <strong>Nolotil <\/strong>\u00e9s un dels <strong>analg\u00e8sics <\/strong>utilitzats a Espanya i un dels medicaments m\u00e9s venuts. No obstant aix\u00f2, <strong>l&#8217;Associaci\u00f3 d&#8217;Afectats per F\u00e0rmacs (ADAF) <\/strong>ha iniciat una <strong><em><span style=\"text-decoration: underline\"><a href=\"https:\/\/www.adafspain.org\/es\/apoyo-campana-nolotil\/\">campanya <\/a><\/span><\/em><\/strong>en contra d&#8217;aquest producte per la <strong>manca d&#8217;informaci\u00f3 que s&#8217;ofereix i els efectes secundaris que provoca.<\/strong><\/p>\n\n\n\n<p>L&#8217;ADAF recorda que el Nolotil &#8220;est\u00e0 prohibit en prop de 40 pa\u00efsos&#8221;. Segons ha informat Antena3, l&#8217;associaci\u00f3 ha presentat una demanda de drets fonamentals davant la negativa del Ministeri de Sanitat i de l&#8217;Ag\u00e8ncia Espanyola de Medicaments i Productes Sanitaris d&#8217;investigar els m\u00e9s de 300 casos de danys provocats pel Nolotil.<br><br>L&#8217;Associaci\u00f3 denuncia que el f\u00e0rmac \u00e9s recetat &#8220;pr\u00e0cticament per a tot&#8221;, com seria el dolor de cap, de dents, genoll, esquena, abans o despr\u00e9s d&#8217;intervencions quir\u00fargiques, sense ni tan sols advertir dels seus riscos. Segons assenyalen, han notificat almenys 350 casos d&#8217;aquests &#8220;efectes secundaris devastadors&#8221;.<\/p>\n\n\n\n<p><strong>Efectes secundaris del Nolotil<\/strong><br><br>L&#8217;associaci\u00f3 assegura que alguns dels efectes secundaris del Nolotil (metamizol) registrats s\u00f3n:*<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Amputacions<\/li>\n\n\n\n<li>Defuncions<\/li>\n\n\n\n<li>Reaccions al\u00b7l\u00e8rgiques greus<\/li>\n\n\n\n<li>Xoc anafil\u00e0ctic<\/li>\n\n\n\n<li>Agranulocitosi <\/li>\n\n\n\n<li>Dany renal o hep\u00e0tic<\/li>\n\n\n\n<li>S\u00e8psia <\/li>\n\n\n\n<li>Fallada multiorg\u00e0nica<br><\/li>\n<\/ul>\n\n\n\n<p><strong>Objectius de la campanya<\/strong><br><strong><br><\/strong>Amb aquesta campanya, l&#8217;Associaci\u00f3 d&#8217;Afectats per Farmacis t\u00e9 tres principals objectius:<\/p>\n\n\n\n<ol class=\"wp-block-list\">\n<li><strong>Aconseguir que es deixi de prescriure el Nolotil. <\/strong>Especialment a persones provinents de pa\u00efsos on est\u00e0 prohibit.<\/li>\n\n\n\n<li>Oferir suport i just\u00edcia als afectats per Nolotil i buscar compensaci\u00f3 pels danys patits. Busquen<strong> responsabilitzar els fabricants i prove\u00efdors d&#8217;aquest medicament <\/strong>pels danys causats presentant demandes legals.<\/li>\n\n\n\n<li>Conscienciaci\u00f3 i <strong>prevenci\u00f3 <\/strong>sobre els efectes d&#8217;aquest medicament.<\/li>\n<\/ol>\n","protected":false},"excerpt":{"rendered":"<p>El Nolotil \u00e9s un dels analg\u00e8sics utilitzats a Espanya i un dels medicaments m\u00e9s venuts. No obstant aix\u00f2, l&#8217;Associaci\u00f3 d&#8217;Afectats per F\u00e0rmacs (ADAF) ha iniciat una campanya en contra d&#8217;aquest producte per la manca d&#8217;informaci\u00f3 que s&#8217;ofereix i els efectes secundaris que provoca.<\/p>\n","protected":false},"author":2313,"featured_media":236086,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_et_pb_use_builder":"","_et_pb_old_content":"","_et_gb_content_width":"","footnotes":""},"categories":[18,10,11,12,13,14,15,294,101],"tags":[188,1456,1680,1704,1748,1866,1867],"class_list":["post-236085","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-general","category-empresarials","category-fefac","category-afb","category-afet","category-afell","category-agfe","category-politica-sanitaria","category-sanitaria","tag-aemps","tag-salut","tag-medicacio","tag-pacient","tag-farmacs","tag-metamizol","tag-nolotil"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Denuncien a Sanitat pels efectes secundaris del Nolotil - FEFAC<\/title>\n<meta name=\"description\" content=\"El Nolotil \u00e9s un dels analg\u00e8sics utilitzats a Espanya i un dels medicaments m\u00e9s venuts. No obstant aix\u00f2, l&#039;Associaci\u00f3 d&#039;Afectats per F\u00e0rmacs (ADAF) ha iniciat una campanya en contra d&#039;aquest producte per la manca d&#039;informaci\u00f3 que s&#039;ofereix i els efectes secundaris que provoca.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/fefac.cat\/empresarial\/denuncien-sanitat-efectes-secundaris-nolotil\/\" \/>\n<meta property=\"og:locale\" content=\"ca_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Denuncien a Sanitat pels efectes secundaris del Nolotil - FEFAC\" \/>\n<meta property=\"og:description\" content=\"El Nolotil \u00e9s un dels analg\u00e8sics utilitzats a Espanya i un dels medicaments m\u00e9s venuts. No obstant aix\u00f2, l&#039;Associaci\u00f3 d&#039;Afectats per F\u00e0rmacs (ADAF) ha iniciat una campanya en contra d&#039;aquest producte per la manca d&#039;informaci\u00f3 que s&#039;ofereix i els efectes secundaris que provoca.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/fefac.cat\/empresarial\/denuncien-sanitat-efectes-secundaris-nolotil\/\" \/>\n<meta property=\"og:site_name\" content=\"FEFAC\" \/>\n<meta property=\"article:published_time\" content=\"2023-11-30T10:09:07+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2023-11-30T10:09:13+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/fefac.cat\/empresarial\/wp-content\/uploads\/2023\/11\/nolotil-scaled.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"2560\" \/>\n\t<meta property=\"og:image:height\" content=\"1600\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"lclavijo@afb.cat\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Escrit per\" \/>\n\t<meta name=\"twitter:data1\" content=\"lclavijo@afb.cat\" \/>\n\t<meta name=\"twitter:label2\" content=\"Temps estimat de lectura\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minuts\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/denuncien-sanitat-efectes-secundaris-nolotil\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/denuncien-sanitat-efectes-secundaris-nolotil\\\/\"},\"author\":{\"name\":\"lclavijo@afb.cat\",\"@id\":\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/#\\\/schema\\\/person\\\/6ac15c94fb359972b6bfa9c752486744\"},\"headline\":\"Denuncien a Sanitat pels efectes secundaris del Nolotil\",\"datePublished\":\"2023-11-30T10:09:07+00:00\",\"dateModified\":\"2023-11-30T10:09:13+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/denuncien-sanitat-efectes-secundaris-nolotil\\\/\"},\"wordCount\":295,\"commentCount\":0,\"image\":{\"@id\":\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/denuncien-sanitat-efectes-secundaris-nolotil\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/wp-content\\\/uploads\\\/2023\\\/11\\\/nolotil-scaled.jpg\",\"keywords\":[\"AEMPS\",\"Salut\",\"medicaci\u00f3\",\"pacient\",\"f\u00e0rmacs\",\"metamizol\",\"nolotil\"],\"articleSection\":[\"General\",\"Empresarials\",\"FEFAC\",\"AFB\",\"AFET\",\"AFELL\",\"AGFE\",\"Pol\u00edtica sanit\u00e0ria\",\"Sanit\u00e0ria\"],\"inLanguage\":\"ca\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/denuncien-sanitat-efectes-secundaris-nolotil\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/denuncien-sanitat-efectes-secundaris-nolotil\\\/\",\"url\":\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/denuncien-sanitat-efectes-secundaris-nolotil\\\/\",\"name\":\"Denuncien a Sanitat pels efectes secundaris del Nolotil - FEFAC\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/denuncien-sanitat-efectes-secundaris-nolotil\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/denuncien-sanitat-efectes-secundaris-nolotil\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/wp-content\\\/uploads\\\/2023\\\/11\\\/nolotil-scaled.jpg\",\"datePublished\":\"2023-11-30T10:09:07+00:00\",\"dateModified\":\"2023-11-30T10:09:13+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/#\\\/schema\\\/person\\\/6ac15c94fb359972b6bfa9c752486744\"},\"description\":\"El Nolotil \u00e9s un dels analg\u00e8sics utilitzats a Espanya i un dels medicaments m\u00e9s venuts. No obstant aix\u00f2, l'Associaci\u00f3 d'Afectats per F\u00e0rmacs (ADAF) ha iniciat una campanya en contra d'aquest producte per la manca d'informaci\u00f3 que s'ofereix i els efectes secundaris que provoca.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/denuncien-sanitat-efectes-secundaris-nolotil\\\/#breadcrumb\"},\"inLanguage\":\"ca\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/denuncien-sanitat-efectes-secundaris-nolotil\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"ca\",\"@id\":\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/denuncien-sanitat-efectes-secundaris-nolotil\\\/#primaryimage\",\"url\":\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/wp-content\\\/uploads\\\/2023\\\/11\\\/nolotil-scaled.jpg\",\"contentUrl\":\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/wp-content\\\/uploads\\\/2023\\\/11\\\/nolotil-scaled.jpg\",\"width\":1200,\"height\":750,\"caption\":\"Nolotil blister on white background. Studio shot with space for text.\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/denuncien-sanitat-efectes-secundaris-nolotil\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Denuncien a Sanitat pels efectes secundaris del Nolotil\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/#website\",\"url\":\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/\",\"name\":\"FEFAC\",\"description\":\"Federaci\u00f3 d&#039;Associacions de Farm\u00e0cies de Catalunya\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"ca\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/#\\\/schema\\\/person\\\/6ac15c94fb359972b6bfa9c752486744\",\"name\":\"lclavijo@afb.cat\",\"url\":\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/author\\\/laura-2\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Denuncien a Sanitat pels efectes secundaris del Nolotil - FEFAC","description":"El Nolotil \u00e9s un dels analg\u00e8sics utilitzats a Espanya i un dels medicaments m\u00e9s venuts. No obstant aix\u00f2, l'Associaci\u00f3 d'Afectats per F\u00e0rmacs (ADAF) ha iniciat una campanya en contra d'aquest producte per la manca d'informaci\u00f3 que s'ofereix i els efectes secundaris que provoca.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/fefac.cat\/empresarial\/denuncien-sanitat-efectes-secundaris-nolotil\/","og_locale":"ca_ES","og_type":"article","og_title":"Denuncien a Sanitat pels efectes secundaris del Nolotil - FEFAC","og_description":"El Nolotil \u00e9s un dels analg\u00e8sics utilitzats a Espanya i un dels medicaments m\u00e9s venuts. No obstant aix\u00f2, l'Associaci\u00f3 d'Afectats per F\u00e0rmacs (ADAF) ha iniciat una campanya en contra d'aquest producte per la manca d'informaci\u00f3 que s'ofereix i els efectes secundaris que provoca.","og_url":"https:\/\/fefac.cat\/empresarial\/denuncien-sanitat-efectes-secundaris-nolotil\/","og_site_name":"FEFAC","article_published_time":"2023-11-30T10:09:07+00:00","article_modified_time":"2023-11-30T10:09:13+00:00","og_image":[{"width":2560,"height":1600,"url":"https:\/\/fefac.cat\/empresarial\/wp-content\/uploads\/2023\/11\/nolotil-scaled.jpg","type":"image\/jpeg"}],"author":"lclavijo@afb.cat","twitter_card":"summary_large_image","twitter_misc":{"Escrit per":"lclavijo@afb.cat","Temps estimat de lectura":"2 minuts"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/fefac.cat\/empresarial\/denuncien-sanitat-efectes-secundaris-nolotil\/#article","isPartOf":{"@id":"https:\/\/fefac.cat\/empresarial\/denuncien-sanitat-efectes-secundaris-nolotil\/"},"author":{"name":"lclavijo@afb.cat","@id":"https:\/\/fefac.cat\/empresarial\/#\/schema\/person\/6ac15c94fb359972b6bfa9c752486744"},"headline":"Denuncien a Sanitat pels efectes secundaris del Nolotil","datePublished":"2023-11-30T10:09:07+00:00","dateModified":"2023-11-30T10:09:13+00:00","mainEntityOfPage":{"@id":"https:\/\/fefac.cat\/empresarial\/denuncien-sanitat-efectes-secundaris-nolotil\/"},"wordCount":295,"commentCount":0,"image":{"@id":"https:\/\/fefac.cat\/empresarial\/denuncien-sanitat-efectes-secundaris-nolotil\/#primaryimage"},"thumbnailUrl":"https:\/\/fefac.cat\/empresarial\/wp-content\/uploads\/2023\/11\/nolotil-scaled.jpg","keywords":["AEMPS","Salut","medicaci\u00f3","pacient","f\u00e0rmacs","metamizol","nolotil"],"articleSection":["General","Empresarials","FEFAC","AFB","AFET","AFELL","AGFE","Pol\u00edtica sanit\u00e0ria","Sanit\u00e0ria"],"inLanguage":"ca","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/fefac.cat\/empresarial\/denuncien-sanitat-efectes-secundaris-nolotil\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/fefac.cat\/empresarial\/denuncien-sanitat-efectes-secundaris-nolotil\/","url":"https:\/\/fefac.cat\/empresarial\/denuncien-sanitat-efectes-secundaris-nolotil\/","name":"Denuncien a Sanitat pels efectes secundaris del Nolotil - FEFAC","isPartOf":{"@id":"https:\/\/fefac.cat\/empresarial\/#website"},"primaryImageOfPage":{"@id":"https:\/\/fefac.cat\/empresarial\/denuncien-sanitat-efectes-secundaris-nolotil\/#primaryimage"},"image":{"@id":"https:\/\/fefac.cat\/empresarial\/denuncien-sanitat-efectes-secundaris-nolotil\/#primaryimage"},"thumbnailUrl":"https:\/\/fefac.cat\/empresarial\/wp-content\/uploads\/2023\/11\/nolotil-scaled.jpg","datePublished":"2023-11-30T10:09:07+00:00","dateModified":"2023-11-30T10:09:13+00:00","author":{"@id":"https:\/\/fefac.cat\/empresarial\/#\/schema\/person\/6ac15c94fb359972b6bfa9c752486744"},"description":"El Nolotil \u00e9s un dels analg\u00e8sics utilitzats a Espanya i un dels medicaments m\u00e9s venuts. No obstant aix\u00f2, l'Associaci\u00f3 d'Afectats per F\u00e0rmacs (ADAF) ha iniciat una campanya en contra d'aquest producte per la manca d'informaci\u00f3 que s'ofereix i els efectes secundaris que provoca.","breadcrumb":{"@id":"https:\/\/fefac.cat\/empresarial\/denuncien-sanitat-efectes-secundaris-nolotil\/#breadcrumb"},"inLanguage":"ca","potentialAction":[{"@type":"ReadAction","target":["https:\/\/fefac.cat\/empresarial\/denuncien-sanitat-efectes-secundaris-nolotil\/"]}]},{"@type":"ImageObject","inLanguage":"ca","@id":"https:\/\/fefac.cat\/empresarial\/denuncien-sanitat-efectes-secundaris-nolotil\/#primaryimage","url":"https:\/\/fefac.cat\/empresarial\/wp-content\/uploads\/2023\/11\/nolotil-scaled.jpg","contentUrl":"https:\/\/fefac.cat\/empresarial\/wp-content\/uploads\/2023\/11\/nolotil-scaled.jpg","width":1200,"height":750,"caption":"Nolotil blister on white background. Studio shot with space for text."},{"@type":"BreadcrumbList","@id":"https:\/\/fefac.cat\/empresarial\/denuncien-sanitat-efectes-secundaris-nolotil\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/fefac.cat\/empresarial\/"},{"@type":"ListItem","position":2,"name":"Denuncien a Sanitat pels efectes secundaris del Nolotil"}]},{"@type":"WebSite","@id":"https:\/\/fefac.cat\/empresarial\/#website","url":"https:\/\/fefac.cat\/empresarial\/","name":"FEFAC","description":"Federaci\u00f3 d&#039;Associacions de Farm\u00e0cies de Catalunya","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/fefac.cat\/empresarial\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"ca"},{"@type":"Person","@id":"https:\/\/fefac.cat\/empresarial\/#\/schema\/person\/6ac15c94fb359972b6bfa9c752486744","name":"lclavijo@afb.cat","url":"https:\/\/fefac.cat\/empresarial\/author\/laura-2\/"}]}},"_links":{"self":[{"href":"https:\/\/fefac.cat\/empresarial\/wp-json\/wp\/v2\/posts\/236085","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/fefac.cat\/empresarial\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/fefac.cat\/empresarial\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/fefac.cat\/empresarial\/wp-json\/wp\/v2\/users\/2313"}],"replies":[{"embeddable":true,"href":"https:\/\/fefac.cat\/empresarial\/wp-json\/wp\/v2\/comments?post=236085"}],"version-history":[{"count":0,"href":"https:\/\/fefac.cat\/empresarial\/wp-json\/wp\/v2\/posts\/236085\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/fefac.cat\/empresarial\/wp-json\/wp\/v2\/media\/236086"}],"wp:attachment":[{"href":"https:\/\/fefac.cat\/empresarial\/wp-json\/wp\/v2\/media?parent=236085"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/fefac.cat\/empresarial\/wp-json\/wp\/v2\/categories?post=236085"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/fefac.cat\/empresarial\/wp-json\/wp\/v2\/tags?post=236085"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}